Directory
>
Klaus Romero
Klaus Romero
Chief Science Officer | Critical Path Institute (C-Path)
Tucson, Arizona, United States
Klaus Romero
Summary
Klaus Romero is a seasoned clinician scientist and CEO at the Critical Path Institute, where he leverages his extensive experience in clinical pharmacology and drug development to enhance efficiency in the pharmaceutical industry. With a strong background in modeling and simulation, he has co-chaired several pivotal workgroups focused on regulatory science and drug trial methodologies. His innovative contributions include the development of clinical trial simulation tools that have undergone regulatory review by the FDA and EMA. Klaus is also an accomplished author with numerous publications in prominent medical journals. He is fluent in four languages, facilitating seamless communication across diverse teams and stakeholders. His leadership is characterized by a collaborative approach that fosters creativity and scientific rigor. Klaus's educational foundation includes multiple master's degrees in epidemiology and pharmacology, reinforcing his expertise in the life sciences. He is passionate about advancing healthcare through integrative scientific thinking and effective drug development processes. Outside of his professional pursuits, he is recognized for his commitment to mentorship and education in the field.
Klaus Romero
Work Experience
Chief Science Officer at
Critical Path Institute (C-Path)
March 2020 - Present
Executive Director Clinical Pharmacology and Quantitative Medicine at
Critical Path Institute (C-Path)
October 2019 - Present
Director of Clinical Pharmacology at
Critical Path Institute (C-Path)
December 2007 - March 2020
Klaus Romero
Education
Columbian Academy of Medicine, Master Of Science (Ms)
January 2004 - January 2006
Columbian National University, Master Of Science (Ms)
January 2002 - January 2004
Pontifical Xavierian University , Doctor Of Medicine (Md)
January 1995 - January 1999
Deutsche Schule Bogotá
Frequently Asked Questions about Klaus Romero
What is Klaus Romero email address?
Klaus Romero's primary email address is *******@c-path.org. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Klaus Romero work for?
Klaus Romero is a Chief Science Officer at Critical Path Institute (C-Path), a company specializing in Commercial physical research.
Where Klaus Romero graduated from?
Klaus Romero holds a degree in Epidemiology from Columbian Academy of Medicine.
How can I directly contact Klaus Romero?
To contact Klaus Romero directly, you can use the email address *******@c-path.org. Complete contact information is available upon registration with Muraena.
Who is Klaus Romero?
Klaus Romero is a seasoned clinician scientist and CEO at the Critical Path Institute, where he leverages his extensive experience in clinical pharmacology and drug development to enhance efficiency in the pharmaceutical industry. With a strong background in modeling and simulation, he has co-chaired several pivotal workgroups focused on regulatory science and drug trial methodologies. His innovative contributions include the development of clinical trial simulation tools that have undergone regulatory review by the FDA and EMA. Klaus is also an accomplished author with numerous publications in prominent medical journals. He is fluent in four languages, facilitating seamless communication across diverse teams and stakeholders. His leadership is characterized by a collaborative approach that fosters creativity and scientific rigor. Klaus's educational foundation includes multiple master's degrees in epidemiology and pharmacology, reinforcing his expertise in the life sciences. He is passionate about advancing healthcare through integrative scientific thinking and effective drug development processes. Outside of his professional pursuits, he is recognized for his commitment to mentorship and education in the field.
Klaus`s contact details
*******@c-path.org
Colleagues
Vice President Global Affairs
Chief Of Staff
Chief Operating Officer
Executive Director, Critical Path for Rare Neurodegenerative Diseases (CP-RND)
Chief Science Officer
Executive Director
Executive Director
Executive Director, Epro Consortium
Executive Director, eCOA Consortium
Executive Director